Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07495332 · ClinicalTrials.gov registry record · NA
Siemens Biomarker Multi-modality
A NA study, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07495332 is a NA study that is actively recruiting participants, run by Duke University. The registered enrollment target is 45 participants.
The verdict
NCT07495332, a NA study, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to see how well Photon Counting CT (PCCT) and ultrasound test results can find fat and scarring in the liver. They will be compared to MRI test results as the reference standard. Participants will get a regular CT scan on the PCCT scanner, plus a few extra pictures just for the study. They will also get an MRI, either on the same day or a different day, whichever is preferred. Participants will get an ultrasound on the same day as the MRI. If they have not had a hematocrit blood test in the past 24 hours, they will also receive one on the day of the CT scan.
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Imaging (MRI)
- DIAGNOSTIC_TEST Ultrasound
- DIAGNOSTIC_TEST Photon-counting CT (PCCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-03-27 |
| Est. Completion | 2027-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07495332
The ClinicalTrials.gov registry entry for NCT07495332 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT07495332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07495332 about?
NCT07495332 is a clinical study titled "Siemens Biomarker Multi-modality". The purpose of this study is to see how well Photon Counting CT (PCCT) and ultrasound test results can find fat and scarring in the liver. They will be compared to MRI test results as the reference standard. Participants will get a regular CT scan on the PCCT scanner, plus a few extra pictures just ...
What is the current status of trial NCT07495332?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-03-27. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07495332?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST), Ultrasound (DIAGNOSTIC_TEST), Photon-counting CT (PCCT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07495332?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.